Partner Research Centers:


Center for Neurodegenerative Disease Research

CNDR in the News

News Feed

  • 01/21/16

    John Trojanowski, MD, PhD, a professor of Pathology and Laboratory Medicine and director of the Institute on Aging, was quoted in a story on MedPage Today about new research which showed the first-ever sign of Tau tangles in vervet monkeys.

  • 01/12/16

    Jason Karlawish, MD, professor of Medicine, Medical Ethics and Health Policy, co-director of the Penn Memory Center and director of the Penn Healthy Brain Research Center, commented to MedPage Today about clinical advances in Alzheimer's care in 2015.

  • 01/12/16

    Darina Petrovsky, RN, MN, a nurse researching the effect of music on memory-impaired patients at the Penn Memory Center, was interview by the Philadelphia Inquirer on the positive effect music can have for patient's with memory loss.

  • 12/14/15

    Angela Bradbury, MD, assistant professor of Hematology/Oncology, was interviewed by KYW radio about Penn's role in a new study in which our genetic counselors will provide telegenetics support, sharing potential participants' genetic risk for Alzheimer's disease.

  • 01/12/16

    The decor in The Easton Home in Easton, PA, comes straight out of the 1930s, '40s and '50s. The old-fashioned rooms in the dementia wing of the elder-care facility are intended to make residents feel at home, help them retrieve memories and get them talking about their younger selves. "Memory units like this, who have made a special effort to create spaces that kindle pleasant memories, make a lot…

  • 09/21/15

    Penn's 4th annual 5K for the IOA and Memory Mile Walk went off without a hitch yesterday morning. The 5K run takes participants through Penn Park and the Memory Mile walk is a scenic stroll through the Penn campus. NBC-10 covered the event.

  • 09/10/15

    Researchers have found evidence that Alzheimer’s disease may be transmissible via extracts contaminated with amyloid-β. They examined the brains of recently deceased patients who received injections of growth hormone derived from the pituitary glands of cadavers. While none of the patients exhibited signs of dementia before their deaths, most had moderate to severe accumulation of amyloid-β in their…

  • 09/10/15

    Research shows that people with a theoretical high risk of developing Parkinson’s disease (PD) have significant cognitive deficits, particularly affecting executive function.The findings emerge from an analysis of 225 participants of the Parkinson Associated Risk Syndrome (PARS) study who undertook a battery of cognitive tests. Daniel Weintraub, MD, associate professor of Geriatric Psychiatry, who…

  • 08/28/15

    Getting older affects every part of the body. Along with the visible changes, our brains aren't as sharp or quick to react anymore. Psychologically and socially too, time takes its toll on us. Why does this happen to us? “There's another way to think about aging, and it's based on evolutionary theory,” F. Bradley Johnson, MD, PhD, associate professor of Pathology and Laboratory Medicine told PhillyVoice.…

  • 09/10/15

    The use of antipsychotic (AP) medication to treat psychosis in Parkinson's disease (PD) increases the risk for all-cause death, and the risk varies with the AP class and the specific drugs within a class, a study shows. "The antipsychotics users had a hazards ratio between 2 and 3 compared with non–antipsychotic users in terms of 6-month mortality, so they were that much more likely to die," Daniel…


Related News Releases

Penn-Engineered Neural Networks Show Hope for Axonal Repair in the Brain, with Minimal Disruption to Brain Tissue

January 19, 2016


Penn's Murray Grossman Receives Special Recognition Award from the Legal Clinic for the Disabled for Dedication to the Disability Community

December 31, 2015


Brain's Hippocampus is Essential Structure for All Aspects of Recognition Memory, Penn Medicine Researchers Find

November 3, 2015


Penn Medicine's John Q. Trojanowski, MD, PhD, Receives Top Honor for Neuropathology Achievement

July 21, 2015


Higher-level Occupations May Increase Survival in Patients with a Common Form of Early-onset Demtia, Finds New Penn Medicine Research

April 22, 2015


Two Penn Medicine Studies Examine Diabetes Severity in Parkinson's and Sex Differences in Parkinson's Caregiving

April 21, 2015


Plasma Ap0A1 Associates with Age at Onset and Motor Severity in Early Parkinson's Disease Patients, Penn Medicine Researchers Find

April 17, 2015


Penn Medicine Researchers Pinpoint Potential New Drug Target for Protection Against Certain Neurodegenerative Diseases

March 20, 2015


Penn Study Uncovers Secrets of a Clump-Dissolving Protein

January 22, 2015


Penn Medicine Biochemist Receives "Bucket Challenge" Funds to Study Biology of Lou Gehrig's Disease

December 17, 2014


Penn Medicine Researchers Receive Funding from CDC to Advance Brain Health

November 13, 2014


Penn Study Finds Dopamine Replacement Therapy Associated with Increase in Impulse Control Disorders Among Early Parkinson's Disease Patients

August 15, 2014


Penn Physiologist Given NIH Javits Neuroscience Investigator Award for Research on Neurodegeneration

August 4, 2014


Penn Medicine Neuropathologist Receives Doris Duke Grant to Study Brain Disorders

August 1, 2014


Penn Researchers Find Naltrexone May Be Effective in Diminishing Impulse Control Disorders in Parkinson's Disease Patients

July 30, 2014


Penn Alzheimer's Researchers to Receive J. Allyn Taylor International Prize in Medicine

July 17, 2014


Penn Medicine Researchers and Collaborators Receive $12.6 Million NIH Grant to Study Genetics of Alzheimer's Disease

July 7, 2014


Penn Study Describes New Models for Testing Parkinson's Disease Immune-based Drugs

June 12, 2014


Quality Control: Penn Study Shows How Misfolded Proteins are Selected for Disposal

May 29, 2014


Can Anti-Depressants Help Prevent Alzheimer's Disease?

May 14, 2014


Role of Calcium in Familial Alzheimer's Disease Clarified in Penn Study, Pointing to New Therapeutic Options

May 13, 2014


Penn Neurologists Report on Promise of Statins, Estrogen and Telemedicine as Potential Targets and Interventions for Parkinson's Disease

April 25, 2014


Penn Medicine Receives $1.45 Million to Speed Research for Rare Neurodegenerative Diseases

April 8, 2014


Penn Medical Ethicist: Policy Changes Urgently Needed as Millions of Americans to Start Receiving Early Label of Alzheimer's Disease

April 7, 2014


Alzheimer's Prevention Trial To Evaluate and Monitor Participants' Reactions to Learning of Higher Disease Risk Status

March 19, 2014


A Common Protein in an Uncommon Role: Unraveling Misfolded Molecules Using "Reprogrammed" Yeast Protein Could Lead to New Brain Disease Therapies

January 16, 2014


Breaking the Brain Clock Predisposes Nerve Cells to Neurodegeneration

November 25, 2013


Penn Medicine Review Finds Statin Use Not Linked to a Decline in Cognitive Function

November 18, 2013


International Group Finds 11 New Alzheimer's Genes to Target for Drug Discovery, Adding New Clues into Complex Disease Puzzle

October 28, 2013


Comprehensive Parkinson's Biomarker Test Has Prognostic and Diagnostic Value, Penn Medicine Team Reports

August 26, 2013


Penn Study Shows Vascular Link in Alzheimer's Disease with Cognition

July 10, 2013


Shape-shifting Disease Proteins May Explain Variable Appearance of Neurodegenerative Diseases, Penn Study Finds

July 3, 2013


Staging System in ALS Shows Potential Tracks of Disease Progression, Penn Study Finds

June 19, 2013